Melanoma Patients' Sentinel Lymph Nodes (SLNS) Play A Strong Role In Disease Prognosis, UCSF Study Reports

ATLANTA -- Researchers at the University of California San Francisco report that melanoma patients whose cancer has spread to their sentinel lymph nodes (SLNs) have a greater chance of experiencing disease recurrence and mortality compared to those whose cancer has not advanced to their SLNs.

The sentinel lymph node (SLN) earned its name because it is the first region in a person's body that receives cancer cells from the place where the disease originated. After cancer cells drain to the SLN, the disease may spread, or metastasize, to other regions of the body. Lymph nodes are the body's first line of defense against infections and cancers. They produce infection-fighting lymphocytes that are distributed via the lymphatic system that functions as a channel of freeways throughout the body.

"Sentinel lymph nodes are a strong marker for predicting a patient's outcomes in regards to disease recurrence and death due to advanced melanoma," says Stanley P.L. Leong, MD, FACS, UCSF professor of surgery and director of the Sentinel Lymph Node program in the UCSF Cancer Center. "We found that patients who have a positive SLN biopsy are more likely to experience a disease recurrence and die from melanoma than those with a negative SLN biopsy."

Leong will present data on the role of SLNs in melanoma today at the American Society for Clinical Oncology (ASCO) meeting.

During the UCSF study, a total of 358 advanced melanoma patients underwent a selective SLN dissection and were followed for a median period of 546 days.

Leong reports that for patients whose cancer spread to their SLNs and therefore had a positive SLN biopsy (63), 78 percent had no evidence of disease and 22 percent experienced recurrent melanoma. Eighty-six percent of these patients remained alive and 14 percent (9) died from melanoma by the end of the study.

For patients with negative SLNs (295), 93 percent showed no evidence of disease and 7 percent developed a recurrence of the dis

Contact: Abby Sinnot
University of California - San Francisco

Page: 1 2 3

Related medicine news :

1. Melanoma vaccine developed at the University of Virginia shows promise in clinical trial
2. University Of Pittsburgh Cancer Institute Defines First Immunologic Markers Of Interferon Effectiveness Against Melanoma
3. Jefferson Researchers Report Progress In Using Vaccinia-Based Vaccine For Melanoma
4. Vaccine Against Melanoma Proves Successful For Patients With Disease Spread To Two Lymph Node Areas
5. DNA-Based Cancer Vaccine Shows Promise To Successfully Treat Melanoma In Mice
6. Caregivers, remember this: Patients medications ease your distress too
7. Patients anaesthesia concerns reviewed
8. Heal thyself: Patients bone marrow cells restore failing hearts
9. Initial Avon/NCI breast cancer research grants awarded in Progress for Patients awards program
10. Patients beliefs and behaviors about health lifestyle and medications may help tailor high blood pressure management method
11. Relaxation And Music Significantly Reduce Patients Postoperative Pain

Post Your Comments:

(Date:9/1/2020)... ... ... Feeding Matters , the first organization in the world dedicated to advancing the ... that the U.S. Centers for Disease Control and Prevention (CDC) has officially approved PFD ... U.S. International Classification of Diseases (ICD ) on October 1, 2021. ...
(Date:9/1/2020)... ... 2020 , ... Dr. Kiran Gill is a Board Certified ... face, breast, and body. In 2018, she founded Aesthetics in Plastic Surgery by ... practice in Southwest Florida. Dr. Gill and her team offer surgical and non-surgical ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) and its international ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean ... face masks to medical first responders across the United States. Since the start ... personal protective equipment (PPE) medical centers , hospitals , firefighters ...
(Date:8/31/2020)... ... 2020 , ... Genesis Chiropractic Software and Billing Network ... of its integrated, HIPAA compliant, telehealth solution, available to US-based clients immediately. With ... seconds. , According to the U.S. Department of Health & Human Services, ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... ... Using Analysis of Variance — A Practical Approach:, Perform Statistical Analysis Without ... https://www.fdanews.com/anova , How much would it help one’s Quality Management System if ... 90 minutes, one can master a powerful statistical technique in that time — Analysis ...
(Date:9/1/2020)... SANTA CLARA, Calif. (PRWEB) , ... September 01, ... ... diagnostics, and analytical laboratory technologies, will host the Agilent Science and Technology ... , During this two-day symposium, Agilent will open a suite of Live webinars ...
(Date:9/1/2020)... ... 01, 2020 , ... September is National Ovarian Cancer Awareness Month. Ovarian ... other cancer of the female reproductive system. The American Cancer Society estimates that ... women will die from this disease. Throughout the month of September, Women’s Excellence ...
Breaking Medicine Technology:
Cached News: